These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 28830352

  • 41. Longdan Xiegan Tang has immunomodulatory effects on CD4+CD25+ T cells and attenuates pathological signs in MRL/lpr mice.
    Lee TY, Chang HH.
    Int J Mol Med; 2010 May; 25(5):677-85. PubMed ID: 20372809
    [Abstract] [Full Text] [Related]

  • 42. Gene expression in B-1 cells from lupus-prone mice.
    Novaes E Brito RR, Xander P, Pérez EC, Maricato JT, Laurindo MF, De Lorenzo BH, Pellegrino R, Bernardo V, Lopes JD, Mariano M.
    Immunol Invest; 2014 May; 43(7):675-92. PubMed ID: 24950194
    [Abstract] [Full Text] [Related]

  • 43. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus.
    Shiroiwa W, Tsukamoto K, Ohtsuji M, Lin Q, Ida A, Kodera S, Ohtsuji N, Nakamura K, Tsurui H, Kinoshita K, Nishimura H, Shirai T, Hirose S.
    Int Immunol; 2007 Feb; 19(2):175-83. PubMed ID: 17189592
    [Abstract] [Full Text] [Related]

  • 44. Granulocytic myeloid-derived suppressor cells contribute to IFN-I signaling activation of B cells and disease progression through the lncRNA NEAT1-BAFF axis in systemic lupus erythematosus.
    Dong G, Yang Y, Li X, Yao X, Zhu Y, Zhang H, Wang H, Ma Q, Zhang J, Shi H, Ning Z, Yan F, Zhai W, Dai J, Li Z, Li C, Ming J, Xue Q, Meng X, Si C, Xiong H.
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan 01; 1866(1):165554. PubMed ID: 31513833
    [Abstract] [Full Text] [Related]

  • 45. Arctigenin inhibits abnormal germinal center reactions and attenuates murine lupus by inhibiting IFN-I pathway.
    Zhang X, Zou M, Liang Y, Yang Y, Jing L, Sun M, Dong Z, Zhang X, Xiong H, Dong G.
    Eur J Pharmacol; 2022 Mar 15; 919():174808. PubMed ID: 35151645
    [Abstract] [Full Text] [Related]

  • 46. NKG2D+CD4+ T Cells Kill Regulatory T Cells in a NKG2D-NKG2D Ligand- Dependent Manner in Systemic Lupus Erythematosus.
    Yang D, Tian Z, Zhang M, Yang W, Tang J, Wu Y, Ni B.
    Sci Rep; 2017 Apr 28; 7(1):1288. PubMed ID: 28455530
    [Abstract] [Full Text] [Related]

  • 47. Suppression of glomerulonephritis in lupus-prone NZB × NZW mice by RN486, a selective inhibitor of Bruton's tyrosine kinase.
    Mina-Osorio P, LaStant J, Keirstead N, Whittard T, Ayala J, Stefanova S, Garrido R, Dimaano N, Hilton H, Giron M, Lau KY, Hang J, Postelnek J, Kim Y, Min S, Patel A, Woods J, Ramanujam M, DeMartino J, Narula S, Xu D.
    Arthritis Rheum; 2013 Sep 28; 65(9):2380-91. PubMed ID: 23754328
    [Abstract] [Full Text] [Related]

  • 48. Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL/lpr and (NZB/NZW)F1 mice.
    Gu F, Molano I, Ruiz P, Sun L, Gilkeson GS.
    Clin Immunol; 2012 Nov 28; 145(2):142-52. PubMed ID: 23041504
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S, Trick D, Sondermann P, Kamino K, Schlegelberger B, Kniesch K, Tiede A, Jacob U, Schmidt RE, Witte T.
    Ann Rheum Dis; 2008 Feb 28; 67(2):154-61. PubMed ID: 17557887
    [Abstract] [Full Text] [Related]

  • 53. Oridonin ameliorates lupus-like symptoms of MRL(lpr/lpr) mice by inhibition of B-cell activating factor (BAFF).
    Zhou L, Sun L, Wu H, Zhang L, Chen M, Liu J, Zhong R.
    Eur J Pharmacol; 2013 Sep 05; 715(1-3):230-7. PubMed ID: 23712004
    [Abstract] [Full Text] [Related]

  • 54. Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference?
    Kyogoku C, Smiljanovic B, Grün JR, Biesen R, Schulte-Wrede U, Häupl T, Hiepe F, Alexander T, Radbruch A, Grützkau A.
    PLoS One; 2013 Sep 05; 8(12):e83776. PubMed ID: 24391825
    [Abstract] [Full Text] [Related]

  • 55. Combined effects of FK506 (tacrolimus) and cyclophosphamide on atypical B220+ T cells, cytokine gene expression and disease activity in MRL/MpJ-lpr/lpr mice.
    Woo J, Wright TM, Lemster B, Borochovitz D, Nalesnik MA, Thomson AW.
    Clin Exp Immunol; 1995 Apr 05; 100(1):118-25. PubMed ID: 7535208
    [Abstract] [Full Text] [Related]

  • 56. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
    Tada Y, Kondo S, Aoki S, Koarada S, Inoue H, Suematsu R, Ohta A, Mak TW, Nagasawa K.
    Arthritis Rheum; 2011 Mar 05; 63(3):738-48. PubMed ID: 21305501
    [Abstract] [Full Text] [Related]

  • 57. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S, Trick D, Kamino K, Matthias T, Kniesch K, Schlegelberger B, Schmidt RE, Witte T.
    Arthritis Rheum; 2005 Nov 05; 52(11):3629-38. PubMed ID: 16255055
    [Abstract] [Full Text] [Related]

  • 58. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Masuyama J, Fujimura A, Kobayashi E, Kano S, Minota S.
    J Rheumatol; 2002 Apr 05; 29(4):707-16. PubMed ID: 11950011
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. JAK-STAT signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients.
    Ji J, Wu Y, Meng Y, Zhang L, Feng G, Xia Y, Xue W, Zhao S, Gu Z, Shao X.
    Acta Biochim Biophys Sin (Shanghai); 2017 Mar 01; 49(3):208-215. PubMed ID: 28177455
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.